Blogs

LinQ Minerals (ASX: LNQ) reported thick copper-gold intercepts at Monza and a potential new system at Gidginbung South, with assays pending, as a 30,000m drilling campaign advances across its Gilmore project in New South Wales.

Aland Equity Group (ASX: AEG): Capital-Light Strategy Advances Property Funds Management Growth

Aland Equity Group (ASX: AEG) is shifting toward capital-light property fund management, with projects including Elm Grove Estate Fund, Villa Estate, and Chinnerys supporting its growth strategy. Investors will be watching project execution, fund returns and future cash flow.

AML3D (ASX: AL3): $2.2M Northrop Grumman Order Advances US Defence Expansion

AML3D (ASX: AL3) has secured a A$2.2 million order from Northrop Grumman Marine Systems, strengthening its US defence presence as it expands manufacturing capacity, grows its sales pipeline and advances commercial opportunities in metal additive manufacturing.

Elevra Lithium (ASX: ELV): 14% Lower Costs and Ewoyaa Cash Fuel Brownfield Expansion

Elevra Lithium (ASX: ELV) reported record mining at North American Lithium, a 14% fall in unit costs and US$71 million from selling Ewoyaa, giving it stronger funding for its brownfield expansion and new offtake deals with LG Energy Solution.

El Dorado Goldfields (ASX: EDO): Guyana Gold Rebrand Pairs with 30-to-1 Share Reset

El Dorado Goldfields (ASX: EDO), formerly Liberty Metals, has rebranded around its Guyana gold projects and asks shareholders on 23 November to back a 30-for-1 share consolidation, three director elections and extra placement capacity at its annual meeting.

Tuas (ASX: TUA): Shares Plunge 30% as Singapore Regulator Questions Simba's Spectrum Use

Tuas (ASX: TUA) shares fell 30% after Singapore's regulator issued Simba a Show Cause Notice over alleged spectrum misuse that could put its licence at risk, despite 24% revenue growth and S$498.8 million in cash in FY26.

Talius Group (ASX: TAL): Revenue Growth and AI-Powered Care Support Expansion

Talius Group (ASX: TAL) reported 47% revenue growth, positive quarterly operating cash flow and 53,958 active subscriptions, while partnering with Health Generation to introduce CareGen Intelligence, an AI-enabled aged care solution.

American Tungsten & Antimony (ASX: AT4): Antimony Progress Puts US Expansion in Focus

American Tungsten & Antimony (ASX: AT4) has reported 99.8% antimony purity from White Spar material processed at Del Sol, while pursuing US expansion through government engagement, a proposed Nasdaq listing and broader feedstock opportunities.

Horseshoe Metals (ASX: HOR): Offtake Interest Grows as Copper Stockpile Approaches First Sale

Horseshoe Metals (ASX: HOR) has sampled its copper stockpiles, upgraded camp power and received multiple non-binding offtake offers as it works toward a first 500 tonne direct shipping ore sale at its Western Australian project.

Pureprofile (ASX: PPL): Record Quarter as Tech Sales Double and Earnings Outpace Revenue

Pureprofile (ASX: PPL) posted record quarterly revenue and earnings as platform sales more than doubled to nearly half of the group, while guidance points to higher margins and a bigger push into the US and UK markets.

Macroeconomic Report Ending 25 October 2026

Macroeconomic Report for the Week Ending 25 October 2026 – Australian Market Outlook

Global markets faced inflation concerns as energy prices surged and economic growth diverged across regions. This report reviews key economic data, central bank outlooks, gold, oil, Bitcoin and ASX 200 sector performance ahead of Australia’s September-quarter CPI release.

Nick Scali (ASX: NCK): Downtrend Intensifies as ANZ Orders Fall 15% and Profit Forecast Deteriorates

Nick Scali (ASX: NCK) expects first-half profit of $28 million to $32 million after ANZ written orders fell 15%, while UK orders rose 29%. Shares rebounded 5% after a sharp sell-off, but the weekly downtrend remains intact.

Elixir Energy (ASX: EXR): $205M Beach Deal Bankrolls Taroom Gas Drive and Reframes Valuation

Elixir Energy (ASX: EXR) has agreed a $205 million farmout of half its Taroom Trough gas acreage to Beach Energy, combining $25 million cash with a four-year carried appraisal program that reduces shareholder funding needs.

Zip Co (ASX: ZIP): Why Shares Crashed? US Growth Was Overshadowed by the Cost of Fraud

Zip Co (ASX: ZIP) reported strong first-quarter US growth and reaffirmed its $340 million earnings target, but a US fraud event and higher credit losses weighed on reported profit and triggered a heavy sell-off in the shares.

Orbital Corporation (ASX: OEC): A$3.7M Power-by-the-Hour Agreement Aims to Drive Recurring Revenue

Orbital Corporation (ASX: OEC) has signed its first Power by the Hour deal with AATI, a US$2.6 million take-or-pay contract through 2027 that could shift the drone engine maker from one-off engine sales towards steadier, recurring service income.

Wisr (ASX: WZR): Stock Climbs as Record Lending Supports Raised FY27 Profit Guidance

Wisr (ASX: WZR) upgraded its FY27 Cash NPAT guidance to at least $7.0 million after record quarterly originations of $253.8 million lifted its loan book 40% to $1.211 billion.

ASX IPOs: What to Check in a Prospectus before You Invest

A new ASX listing can look exciting on day one, but the prospectus holds the facts. Here is how Australian investors can assess an IPO, read the key sections, and spot red flags before applying for shares.

Sarama Resources (ASX: SRR): Shareholders Support All Resolutions as Explorer Targets Copper and Gold

Sarama Resources (ASX: SRR) shareholders passed all 14 resolutions at the annual meeting, clearing director placements, equity incentives and a 10% placement facility as the explorer shifts focus to copper-gold and its Burkina Faso arbitration claim.

NEXTDC (ASX: NXT): Stalled Grid Upgrade Makes A$8.7B Liquidity the Primary Safety Net

NEXTDC (ASX: NXT) has cut its FY27 guidance after Jemena suspended grid works at its Melbourne M3 data centre, deferring contracted revenue into FY28, while the company pauses uncontracted projects and reviews its capital spending plans.

SomnoMed (ASX: SOM): Jumps 23% From Yearly Low as Europe Reset Tests Growth Story

Oct 21, 2026

SomnoMed (ASX: SOM) shares jumped 23% to $0.29 near their yearly low, as the sleep apnoea device maker weighs a European reimbursement reset against North American growth and wider margins after FY26 EBITDA rose 19%.

Overwatch Technologies (ASX: OWL): IPO Puts Maritime Surveillance Growth Prospects in Focus

Oct 21, 2026